Stifel analyst Justin Keywood maintained his “Buy” rating and C$9.00 target price for WELL Health Technologies (WELL Health Stock Quote, Chart, News, Analysts, Financials TSX:WELL) in a Sept. 29th note, arguing that recent Canadian healthcare take-outs highlight a disconnect between public market valuations and fair value for assets with strong secular tailwinds. He pointed to […]
Roth Capital Markets analyst Scott Searle reiterated a “Buy” rating and US$4.50 price target on Genasys (Genasys Stock Quote, Chart, News, Analysts, Financials NASDAQ:GNSS) in a Sept. 30 update, pointing to a meaningful milestone with the company’s first order under the U.S. Army’s Common Remotely Operated Weapon Stations (CROWS) program. After the close on Sept. […]
Share
Tweet
Share
